# Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE)

> **NCT03252717** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Institut du Cancer de Montpellier - Val d'Aurelle** · enrollment: 500 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** Blood sample

## Key facts

- **NCT ID:** NCT03252717
- **Lead sponsor:** Institut du Cancer de Montpellier - Val d'Aurelle
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-08
- **Primary completion:** 2017-08-31
- **Final completion:** —
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03252717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03252717, "Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03252717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*